The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
150 jobs Number of planned job losses
Announcement Date
13 October 2017
Employment effect (start)
1 January 2018
Foreseen end date
31 March 2018
Description
On 13 October 2017, the German pharmaceutical company Salutas Pharma GmbH confirmed the loss of 150 jobs at its site in Barleben due to internal restructuring. The job reduction process will take place in the first quarter of 2018. Management argues that cuts are inevitable due to a decline in sales from 10 billion pills per year to 8 billion pills per year.
Works council and management have started negotiations regarding a social plan.
As of October 2017, Salutas Pharma GmbH has 1,172 employees in Barleben.
Sources
13 October 2017: MDR Online
13 October 2017: Volksstimme Online
Citation
Eurofound (2017), Salutas Pharma, Internal restructuring in Germany, factsheet number 92310, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/92310.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
